Figures computed from official regulatory filings — .
Ownershipinsiders 57.89% · institutions 0.01%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Nuo Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
198 buys63 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| JORDEN DAVID EMERSONtrack record | Buy | $844.2 | conv 37 |
| SEC |
| JORDEN DAVID EMERSONtrack record | Buy | $8.7K | conv 30 | SEC |
| JORDEN DAVID EMERSONtrack record | Exercise | $162.5K | SEC |
| JORDEN DAVID EMERSONtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CLAUSEN PETER | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| JORDEN DAVID EMERSONtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WINZER C ERIC | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pittman Scott M.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WINZER C ERIC | Exercise | $40K | SEC |
| Pittman Scott M.track record | Other | $40K | SEC |
| Mintz Paul | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| JORDEN DAVID EMERSONtrack record | Other | $162.5K | Unusual size | SEC |
| WINZER C ERIC | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WINZER C ERIC | Other | $40K | SEC |
| Pittman Scott M.track record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pittman Scott M.track record | Exercise | $40K | SEC |
| JORDEN DAVID EMERSONtrack record | Award | $14.5K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $11.3K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $26.3K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $26.2K | SEC |
| Pittman Scott M.track record | OtherD (derivative) | $11.3K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $11K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $45.1K | SEC |
| Pittman Scott M.track record | AwardD (derivative) | $55.1K | SEC |
| Pittman Scott M.track record | OtherD (derivative) | $55.1K | SEC |